Abacus FCF Advisors LLC raised its stake in Ingredion Incorporated (NYSE:INGR - Free Report) by 46.0% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 25,566 shares of the company's stock after purchasing an additional 8,060 shares during the quarter. Abacus FCF Advisors LLC's holdings in Ingredion were worth $3,517,000 as of its most recent filing with the Securities & Exchange Commission.
Other institutional investors and hedge funds have also recently modified their holdings of the company. Renaissance Technologies LLC raised its holdings in shares of Ingredion by 234.1% in the fourth quarter. Renaissance Technologies LLC now owns 140,000 shares of the company's stock valued at $19,258,000 after purchasing an additional 98,100 shares during the last quarter. Invesco Ltd. increased its stake in Ingredion by 5.7% in the 4th quarter. Invesco Ltd. now owns 870,317 shares of the company's stock valued at $119,721,000 after buying an additional 46,819 shares during the last quarter. Polymer Capital Management US LLC bought a new position in shares of Ingredion during the 4th quarter worth approximately $356,000. Cerity Partners LLC boosted its stake in shares of Ingredion by 12.0% in the 4th quarter. Cerity Partners LLC now owns 20,941 shares of the company's stock worth $2,880,000 after buying an additional 2,250 shares during the last quarter. Finally, Aristides Capital LLC grew its holdings in shares of Ingredion by 30.2% in the fourth quarter. Aristides Capital LLC now owns 2,158 shares of the company's stock valued at $297,000 after acquiring an additional 500 shares in the last quarter. 85.27% of the stock is owned by hedge funds and other institutional investors.
Ingredion Stock Performance
NYSE INGR traded up $2.37 during trading on Friday, hitting $129.88. 490,496 shares of the company's stock traded hands, compared to its average volume of 459,829. The company has a debt-to-equity ratio of 0.47, a quick ratio of 1.69 and a current ratio of 2.62. The stock has a market capitalization of $8.34 billion, a price-to-earnings ratio of 13.38, a PEG ratio of 1.03 and a beta of 0.72. Ingredion Incorporated has a 12-month low of $109.51 and a 12-month high of $155.44. The business has a 50 day moving average of $130.28 and a 200-day moving average of $136.01.
Ingredion (NYSE:INGR - Get Free Report) last announced its quarterly earnings results on Tuesday, February 4th. The company reported $2.63 EPS for the quarter, beating analysts' consensus estimates of $2.54 by $0.09. Ingredion had a net margin of 8.71% and a return on equity of 18.62%. The company had revenue of $1.80 billion for the quarter, compared to analysts' expectations of $1.82 billion. During the same period in the prior year, the company posted $1.65 EPS. Ingredion's revenue was down 6.3% compared to the same quarter last year. As a group, equities research analysts anticipate that Ingredion Incorporated will post 11.14 earnings per share for the current fiscal year.
Ingredion Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, April 22nd. Investors of record on Tuesday, April 1st will be paid a dividend of $0.80 per share. The ex-dividend date is Tuesday, April 1st. This represents a $3.20 dividend on an annualized basis and a dividend yield of 2.46%. Ingredion's payout ratio is 32.96%.
Insider Buying and Selling
In other Ingredion news, CEO James P. Zallie sold 10,815 shares of the stock in a transaction that occurred on Wednesday, February 19th. The shares were sold at an average price of $125.88, for a total value of $1,361,392.20. Following the sale, the chief executive officer now directly owns 34,127 shares in the company, valued at $4,295,906.76. This represents a 24.06 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. 1.80% of the stock is currently owned by insiders.
Wall Street Analysts Forecast Growth
A number of analysts recently commented on INGR shares. UBS Group reiterated a "neutral" rating and set a $145.00 price target (down from $165.00) on shares of Ingredion in a report on Monday, April 7th. Stephens lowered their target price on Ingredion from $155.00 to $150.00 and set an "equal weight" rating on the stock in a research note on Wednesday, February 5th. BMO Capital Markets reduced their price target on shares of Ingredion from $147.00 to $133.00 and set a "market perform" rating for the company in a research report on Wednesday, February 5th. StockNews.com lowered shares of Ingredion from a "strong-buy" rating to a "buy" rating in a research report on Thursday, February 6th. Finally, Oppenheimer reduced their target price on shares of Ingredion from $178.00 to $167.00 and set an "outperform" rating for the company in a research report on Wednesday, February 5th. Three equities research analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and an average target price of $152.60.
View Our Latest Stock Report on Ingredion
Ingredion Profile
(
Free Report)
Ingredion Incorporated, together with its subsidiaries, manufactures and sells sweeteners, starches, nutrition ingredients, and biomaterial solutions derived from wet milling and processing corn, and other starch-based materials to a range of industries in North America, South America, the Asia Pacific, Europe, the Middle East, and Africa.
Read More

Before you consider Ingredion, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ingredion wasn't on the list.
While Ingredion currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for April 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.